Indigenous dengue vaccine trials at AIIMS Bibinagar

Indigenous dengue vaccine trials at AIIMS Bibinagar

Hyderabad: The All India Institute of Medical Sciences (AIIMS) in Bibinagar has been selected as a crucial site for the Phase III clinical trial of India’s first indigenous dengue vaccine, “DengiAll.” The trial is a collaborative effort between the Indian Council of Medical Research (ICMR) and the biotechnology company Panacea Biotec. The vaccine, a single-dose tetravalent, live-attenuated formulation, is being tested to combat all four serotype…